Xwell Inc (XWEL)

XWELL, Inc. is a common stock listing on the NASDAQ exchange. The company provides health and wellness services for travelers in the United States and abroad through several operating segments. Its XpresSpa business focuses on spa services such as massage, nail care, and skin care, along with related travel and spa products. The XpresTest segment has provided diagnostic COVID-19 testing at airports, operated XpresCheck Wellness Centers, supported the CDC’s bio-surveillance program, and delivered marketing services through HyperPointe to health-related channels. The Naples Wax Center segment offers waxing services and skincare products, while Treat gives travelers access to wellness services through on-site centers. XWELL also sells services through stores, kiosks, and online channels. The company is based in New York, New York, and was formerly known as XpresSpa Group, Inc. before adopting its current name in October 2022.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-XWEL
$1.01
13.7% Upside
Fair
Not available
Not available
Weak
0.0%
November 13, 2026
0.3x
7.666 M
13.285 M
29.0%
67.7%
-33.8
40.4%
Valuation • Fair Value

Xwell Inc (NASDAQ-XWEL) Fair Value by Valuation Model

Review the available estimates for Xwell Inc (NASDAQ-XWEL), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$1.01

Estimated upside of 13.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.96

Discounted cash flow valuation reference.

Comps Fair Value

$1.03

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Xwell Inc (NASDAQ-XWEL) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Xwell Inc (NASDAQ-XWEL)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

28.282 M

Current operating scale indicator.

Revenue Forecast

29.21 M

Forward revenue estimate.

EBITDA

-9.941 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Xwell Inc (NASDAQ-XWEL) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Xwell Inc (NASDAQ-XWEL)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-7.60

No elevated caution signal from this screen.

Altman Z-Score

-33.8

Lower score that deserves closer risk review.

FCF / Net Income

40.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Xwell Inc (NASDAQ-XWEL). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Xwell Inc (NASDAQ-XWEL)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 13, 2026

Days to Earnings

52

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Xwell Inc (NASDAQ-XWEL), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Xwell Inc (NASDAQ-XWEL) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for Xwell Inc (NASDAQ-XWEL) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Xwell Inc (NASDAQ-XWEL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Xwell Inc (NASDAQ-XWEL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Xwell Inc (NASDAQ-XWEL) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Xwell Inc (NASDAQ-XWEL) Stock FAQ

Data-supported answers about Xwell Inc (NASDAQ-XWEL), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$1.01
Estimated upside 13.7%
Valuation Rating
Undervalued
Estimated upside of 13.7%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Xwell Inc (NASDAQ-XWEL) is $1.01. This implies an estimated upside of 13.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 13.7% versus the current market price.

The current financial health read for Xwell Inc (NASDAQ-XWEL) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Xwell Inc (NASDAQ-XWEL) is November 13, 2026.

The latest available data indicates no current dividend yield for Xwell Inc (NASDAQ-XWEL).

The current market capitalization listed for Xwell Inc is 7.666 M.

The current enterprise value listed for Xwell Inc is 13.285 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Xwell Inc is NASDAQ-XWEL, and the stock is listed on NASDAQ.

Xwell Inc (NASDAQ-XWEL) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Xwell Inc is 29.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Xwell Inc is 67.7%. Free float helps investors understand how much of the share base is available for public trading.